Showing results (101-110 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|September 11, 2020
Implementation and Clinical Utility of an Integrated Academic-Community Regional Molecular Tumor BoardMark E Burkard, Dustin A Deming, Benjamin M Parsons, et al.
JCO Precision Oncology|September 11, 2020
Exploratory Analysis of Single-Gene Predictive Biomarkers in HERA DASL Cohort Reveals That C8A mRNA Expression Is Prognostic of Outcome and Predictive of Benefit of TrastuzumabScooter Willis, Varvara Polydoropoulou, Yuliang Sun, et al.
JCO Precision Oncology|September 11, 2020
Outcomes of Chemotherapy for Microsatellite Instable-High Metastatic Colorectal CancersKaterina Shulman, Ofra Barnett-Griness, Vered Friedman, et al.
JCO Precision Oncology|September 11, 2020
Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 TrialClémence Basse, Claire Morel, Céline Callens, et al.
JCO Precision Oncology|September 11, 2020
Predictive Biomarkers in Metastatic Colorectal Cancer: A Systematic ReviewJuan Ruiz-Bañobre, Raju Kandimalla, Ajay Goel
JCO Precision Oncology|September 11, 2020
Use of a Targeted Exome Next-Generation Sequencing Panel Offers Therapeutic Opportunity and Clinical Benefit in a Subset of Patients With Advanced CancersScott Kopetz, Kenna R Mills Shaw, J Jack Lee, et al.
JCO Precision Oncology|September 11, 2020
Comprehensive Genomic Analysis of Metastatic Non-Clear-Cell Renal Cell Carcinoma to Identify Therapeutic TargetsMaria I Carlo, Nabeela Khan, Ahmet Zehir, et al.
JCO Precision Oncology|September 11, 2020
Genomic Analysis of Metastatic Solid Tumors in Veterans: Findings From the VHA National Precision Oncology ProgramPradeep J Poonnen, Jill E Duffy, Bradley Hintze, et al.
JCO Precision Oncology|September 11, 2020
Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic MelanomaRenáta Váraljai, Kilian Wistuba-Hamprecht, Teofila Seremet, et al.
JCO Precision Oncology|September 11, 2020
Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian CancerYuki Himoto, Harini Veeraraghavan, Junting Zheng, et al.
Pageof 140